Furthermore, the data on 6-fold-increased ovarian cancer risk in women carriers of combined “risk” genotypes (GSTT1-active/GSTP1*Ile) suggest a high probability of their synergetic risk effect on carcinogenesis in these women [51]. This evidence concerns the gene GSTP1 and ovarian carcinoma.